Schedule 13G ownership disclosure

CALIDI BIOTHERAPEUTICS INC

Security class unavailable · CUSIP: 320703309

Event date: 2024-09-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001937147-24-000008
Form type
SC 13G
Filer
Calidi Biotherapeutics, Inc.
CIK
CIK 1855485
Filed
Sep 11, 2024
Reporting period
Sep 04, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub